Prescription Drug Abuse Elimination Act of 2006

Bill: 109-hr-4769
Sponsor: Rep. Norwood, Charles W. [R-GA-9]
Introduced: 2006-02-16 in the House
Policy area: Health
Subjects: Accreditation (Medical care)
Administrative procedure
Business records
Commerce
Communication in medicine
Congress
Congressional reporting requirements
Consumer education
Crime and Law Enforcement
Data banks
Death
Department of Health and Human Services
Drug abuse
Drug addiction
Drug industry
Drug law enforcement
Drugs
Economics and Public Finance
Electronic commerce
Electronic data interchange
Federal advisory bodies
Federal aid to health facilities
Federal-state relations
Foreign Trade and International Finance
Generic drugs
Government Operations and Politics
Government paperwork
Governmental investigations
Health information systems
Health surveys
Identification devices
Import restrictions
Imports
Injunctions
Intellectual property
Interactive media
Internet
Labeling
Law
Medical personnel
Medical records
Medical statistics
Medication abuse
Packaging
Pharmacies
Pharmacists
Product counterfeiting
Science, Technology, Communications
Web sites

Summary:
action_date: 2006-02-16
text: 
Prescription Drug Abuse Elimination Act of 2006 -Amends the Federal Food, Drug, and Cosmetic Act to require Internet pharmacies to meet specified criteria, including: (1) providing individuals who access the pharmacy with certain information; (2) obtaining verification of a valid prescription in some circumstances; and (3) providing contact information of the individual dispensing prescription drugs on the site to each state that licenses or authorizes the person to dispense drugs. Prohibits the sale of a prescription drug, or the ownership or operation of an illegal Internet pharmacy, in violation of the requirements of this Act. Allows district courts to order Internet providers to remove access or links to sites that violate this Act.
 
Directs the Secretary of Health and Human Services to promulgate chain-of-custody requirements to track prescription drugs from the manufacturer through each importer, distributor, and retailer. Deems a drug misbranded if such requirements are not met.
 
Amends the Controlled Substances Import and Export Act to restrict the importation of a schedule II, III, or IV drug by a U.S. resident without a valid prescription to once during any 30-day period. 
 
Requires the Secretary, acting through the Commissioner of Food and Drugs, to: (1) convene a working group to study and report on pharmaceutical counterfeiting; and (2) study the best methods to ensure that controlled substances are not diverted for unlawful use.
 
Requires the Secretary to conduct research and report on issues related to prescription drug abuse.
 
Requires the Administrator of the Substance Abuse and Mental Health Services Administration to maintain a comprehensive, national database on deaths occurring as a result of substance abuse.


Legislative actions:
action_date: 2006-02-17
text: Referred to the Subcommittee on Health.
action_date: 2006-02-16
text: Referred to the House Committee on Energy and Commerce.
action_date: 2006-02-16
text: Introduced in House
action_date: 2006-02-16
text: Introduced in House